Press release
Intravenous Immunoglobulin Market: Rising Demand for IVIG Therapy Drives Market Growth and Therapeutic Advancements
The IVIG market has experienced significant growth over the years and is expected to continue growing in the future. The increasing prevalence of immunodeficiency disorders, autoimmune diseases, and neurological disorders is driving the demand for IVIG.
Rising Demand: IVIG is used for the treatment of various conditions, including primary immunodeficiency disorders, chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain-Barré syndrome (GBS), and immune thrombocytopenic purpura (ITP). The growing awareness about the benefits of IVIG therapy and advancements in healthcare infrastructure are leading to an increased demand for IVIG products.
Therapeutic Applications: IVIG is extensively used in the treatment of immune deficiencies, particularly primary immunodeficiency disorders (PIDD). It is also employed in the management of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis. Additionally, IVIG is used for neurological disorders like Alzheimer's disease, multiple sclerosis, and myasthenia gravis.
Increasing Research and Development: Pharmaceutical companies are investing in research and development activities to develop improved formulations and delivery methods for IVIG products. This includes the development of subcutaneous IVIG, which offers advantages such as reduced infusion time and increased patient convenience.
Competitive Landscape: The IVIG market is characterized by the presence of several key players, including pharmaceutical companies and biotechnology firms. Some prominent companies in this market include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, and Takeda Pharmaceuticals. These companies are focusing on expanding their product portfolios, geographical presence, and strategic collaborations to gain a competitive edge.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/325
Market Drivers:
Increasing Prevalence of Immunodeficiency Disorders: The rising incidence and prevalence of primary immunodeficiency disorders (PIDD) are driving the demand for IVIG. PIDDs are a group of genetic disorders that impair the immune system's ability to defend against infections. IVIG therapy helps replace the deficient antibodies in individuals with PIDD, thereby boosting their immune response.
Growing Awareness and Diagnosis of Autoimmune Diseases: Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis, are becoming increasingly prevalent worldwide. IVIG is used in the treatment of these conditions to modulate the immune response and reduce disease activity. The growing awareness and improved diagnostic techniques for autoimmune diseases are leading to an increased demand for IVIG.
Expansion of Therapeutic Applications: IVIG has shown efficacy in treating an expanding range of conditions beyond immunodeficiency and autoimmune diseases. It is used in the management of neurological disorders like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease. The widening therapeutic applications of IVIG are driving its market growth.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/325
Market Segmentation:
Indication:
a. Primary Immunodeficiency Disorders (PIDD): IVIG is extensively used for the treatment of various primary immunodeficiency disorders, including X-linked agammaglobulinemia, common variable immunodeficiency (CVID), and selective IgA deficiency.
b. Autoimmune Diseases: IVIG is employed in the management of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis.
c. Neurological Disorders: IVIG is utilized for the treatment of neurological conditions like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease.
Formulation:
a. Liquid IVIG: The most common form of IVIG is the liquid formulation, which is available in various concentrations and administered via intravenous infusion.
b. Lyophilized IVIG: Lyophilized or freeze-dried IVIG requires reconstitution with sterile water before administration. It offers advantages such as extended shelf life and ease of storage.
End User:
a. Hospitals and Clinics: IVIG therapy is predominantly administered in hospitals and outpatient clinics, where healthcare professionals can closely monitor patients during the infusion process.
b. Homecare Settings: With the development of subcutaneous IVIG formulations, there is an increasing trend of IVIG administration in homecare settings, allowing patients to receive treatment in the comfort of their homes.
Geography:
The IVIG market can be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region may have different market dynamics influenced by factors such as healthcare infrastructure, reimbursement policies, regulatory frameworks, and patient demographics.
Distribution Channel:
a. Hospital Pharmacies: IVIG products are commonly procured and distributed through hospital pharmacies.
b. Retail Pharmacies: Some IVIG products may also be available through retail pharmacies, enabling patients to fill prescriptions and access IVIG treatment conveniently.
These segmentation categories help in analyzing the market, understanding specific patient needs, and tailoring marketing strategies to target different customer segments effectively.
Procure Complete Report : https://www.alliedmarketresearch.com/purchase-enquiry/325
Competitive Landscape:
CSL Behring
Grifols
Takeda Pharmaceuticals
Kedrion Biopharma
Octapharma
Baxter International Inc.
China Biologic Products Holdings, Inc.
Shire (now part of Takeda Pharmaceuticals)
Biotest AG
LFB Group
Related Reports :
Medical Implant Market
Advanced Wound Care Market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Rising Demand: IVIG is used for the treatment of various conditions, including primary immunodeficiency disorders, chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain-Barré syndrome (GBS), and immune thrombocytopenic purpura (ITP). The growing awareness about the benefits of IVIG therapy and advancements in healthcare infrastructure are leading to an increased demand for IVIG products.
Therapeutic Applications: IVIG is extensively used in the treatment of immune deficiencies, particularly primary immunodeficiency disorders (PIDD). It is also employed in the management of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis. Additionally, IVIG is used for neurological disorders like Alzheimer's disease, multiple sclerosis, and myasthenia gravis.
Increasing Research and Development: Pharmaceutical companies are investing in research and development activities to develop improved formulations and delivery methods for IVIG products. This includes the development of subcutaneous IVIG, which offers advantages such as reduced infusion time and increased patient convenience.
Competitive Landscape: The IVIG market is characterized by the presence of several key players, including pharmaceutical companies and biotechnology firms. Some prominent companies in this market include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, and Takeda Pharmaceuticals. These companies are focusing on expanding their product portfolios, geographical presence, and strategic collaborations to gain a competitive edge.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/325
Market Drivers:
Increasing Prevalence of Immunodeficiency Disorders: The rising incidence and prevalence of primary immunodeficiency disorders (PIDD) are driving the demand for IVIG. PIDDs are a group of genetic disorders that impair the immune system's ability to defend against infections. IVIG therapy helps replace the deficient antibodies in individuals with PIDD, thereby boosting their immune response.
Growing Awareness and Diagnosis of Autoimmune Diseases: Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis, are becoming increasingly prevalent worldwide. IVIG is used in the treatment of these conditions to modulate the immune response and reduce disease activity. The growing awareness and improved diagnostic techniques for autoimmune diseases are leading to an increased demand for IVIG.
Expansion of Therapeutic Applications: IVIG has shown efficacy in treating an expanding range of conditions beyond immunodeficiency and autoimmune diseases. It is used in the management of neurological disorders like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease. The widening therapeutic applications of IVIG are driving its market growth.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/325
Market Segmentation:
Indication:
a. Primary Immunodeficiency Disorders (PIDD): IVIG is extensively used for the treatment of various primary immunodeficiency disorders, including X-linked agammaglobulinemia, common variable immunodeficiency (CVID), and selective IgA deficiency.
b. Autoimmune Diseases: IVIG is employed in the management of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis.
c. Neurological Disorders: IVIG is utilized for the treatment of neurological conditions like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease.
Formulation:
a. Liquid IVIG: The most common form of IVIG is the liquid formulation, which is available in various concentrations and administered via intravenous infusion.
b. Lyophilized IVIG: Lyophilized or freeze-dried IVIG requires reconstitution with sterile water before administration. It offers advantages such as extended shelf life and ease of storage.
End User:
a. Hospitals and Clinics: IVIG therapy is predominantly administered in hospitals and outpatient clinics, where healthcare professionals can closely monitor patients during the infusion process.
b. Homecare Settings: With the development of subcutaneous IVIG formulations, there is an increasing trend of IVIG administration in homecare settings, allowing patients to receive treatment in the comfort of their homes.
Geography:
The IVIG market can be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region may have different market dynamics influenced by factors such as healthcare infrastructure, reimbursement policies, regulatory frameworks, and patient demographics.
Distribution Channel:
a. Hospital Pharmacies: IVIG products are commonly procured and distributed through hospital pharmacies.
b. Retail Pharmacies: Some IVIG products may also be available through retail pharmacies, enabling patients to fill prescriptions and access IVIG treatment conveniently.
These segmentation categories help in analyzing the market, understanding specific patient needs, and tailoring marketing strategies to target different customer segments effectively.
Procure Complete Report : https://www.alliedmarketresearch.com/purchase-enquiry/325
Competitive Landscape:
CSL Behring
Grifols
Takeda Pharmaceuticals
Kedrion Biopharma
Octapharma
Baxter International Inc.
China Biologic Products Holdings, Inc.
Shire (now part of Takeda Pharmaceuticals)
Biotest AG
LFB Group
Related Reports :
Medical Implant Market
Advanced Wound Care Market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
